Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.21.1
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended
Jun. 30, 2019
May 02, 2021
May 03, 2020
Mar. 31, 2021
Stockholders' Equity (Details) [Line Items]        
Cashless warrant exercised (in Shares)   1,125    
Stock options are subject to vesting percentage 100.00%      
Stock price $ 75      
Stock option modified (in Shares) 495,366      
Additional compensation $ 874,000      
Modification and remaining expense was recognized $ 315,000      
2017 Equity Incentive Plan [Member]        
Stockholders' Equity (Details) [Line Items]        
Granted term   10 years    
Common stock reserved issuance (in Shares)       2,104,889
Non statutory stock options granted (in Shares) 495,366      
Stock option price exercise (in Dollars per share) $ 38.10      
Equity based compensation expense   $ 700,000 $ 900,000  
Total unrecognized equity based compensation cost related to unvested stock option and restricted unit awards   $ 4,512,543    
Weighted average period   2 years 3 months    
Warrant [Member]        
Stockholders' Equity (Details) [Line Items]        
Issuance of common shares (in Shares)   2,106